Advocacy intelligence hub — real-time data for patient organizations
Zhenzhen Liu — NA
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University — PHASE2
Sichuan Baili Pharmaceutical Co., Ltd. — PHASE3
Vertex Pharmaceuticals Incorporated — PHASE2
Shanghai JMT-Bio Inc. — PHASE3
University of Valencia — NA
Sichuan Baili Pharmaceutical Co., Ltd. — PHASE3
Vertex Pharmaceuticals Incorporated — PHASE1, PHASE2
Jiangsu HengRui Medicine Co., Ltd. — PHASE3
Zheng Yabing — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Global Clinical Leader
Daiichi Sankyo
Thurman M. Wheeler, MD, M.D
Massachusetts General Hospital
📍 ROCHESTER, NY
Laurent Servais, MD
Centre Hospitalier Universitaire de Liege
Araya Puwanant, MD, MS, MD
Wake Forest University Health Sciences
📍 WINSTON-SALEM, NC
Johann Hamel, MD
University of Rochester Medical Center, Department of Neurology
Pascal LAFORÊT, MD, PhD
Neurology Department, Raymond Poincaré Hospital, APHP